4//SEC Filing
Smith Christopher M 4
Accession 0001077183-24-000028
CIK 0001077183other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:28 PM ET
Size
17.2 KB
Accession
0001077183-24-000028
Insider Transaction Report
Form 4
Smith Christopher M
Chief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-23+287,940→ 287,940 totalExercise: $16.45Exp: 2034-02-23→ Common Stock (287,940 underlying) - Award
Restricted Stock Unit
2024-02-23+172,239→ 172,239 totalExercise: $0.00→ Common Stock (172,239 underlying) - Award
Performance Stock Unit
2024-02-23+172,240→ 172,240 totalExercise: $0.00From: 2027-02-23→ Common Stock (172,240 underlying)
Holdings
- 602,219
Common Stock
- 694,444
Stock Option (Right to Buy)
Exercise: $12.62Exp: 2029-08-15→ Common Stock (694,444 underlying) - 269,841
Stock Option (Right to Buy)
Exercise: $19.65Exp: 2030-05-11→ Common Stock (269,841 underlying) - 144,190
Restricted Stock Unit
Exercise: $0.00→ Common Stock (144,190 underlying) - 144,190
Performance Stock Unit
Exercise: $0.00From: 2026-05-11→ Common Stock (144,190 underlying)
Footnotes (8)
- [F1]On August 15, 2022, Mr. Smith was granted 694,444 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F2]On May 11, 2023, Mr. Smith was granted 269,841 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On May 11, 2023, Mr. Smith was granted 144,190 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F4]Once vested, the shares of common stock are not subject to expiration.
- [F5]On May 11, 2023, Mr. Smith was granted 144,190 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 216,285. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
- [F6]On February 23, 2024, Mr. Smith was granted 287,940 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F7]On February 23, 2024, Mr. Smith was granted 172,239 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F8]On February 23, 2024, Mr. Smith was granted 172,240 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 258,360. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001436707
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:28 PM ET
- Size
- 17.2 KB